Oncology
2366 articles · 70 journals
Journals in this subcategory (70)
- Blood Neoplasia · Elsevier (100)
- European Journal of Surgical Oncology · Elsevier (95)
- Cancer Treatment and Research Communications · Elsevier (93)
- The Lancet Oncology · Elsevier (93)
- Brachytherapy · Elsevier (91)
- Cancer Epidemiology · Elsevier (90)
- Biochimica et Biophysica Acta: Reviews on Cancer · Elsevier (89)
- International Journal of Gynecological Cancer · Elsevier (88)
- EJC Skin Cancer · Elsevier (85)
- Journal of Thoracic Oncology · Elsevier (84)
- Lung Cancer · Elsevier (77)
- Asia-Pacific Journal of Clinical Oncology · Wiley (76)
- Critical Reviews in Oncology/Hematology · Elsevier (70)
- Urologic Oncology: Seminars and Original Investigations · Elsevier (68)
- Surgical Oncology Clinics of North America · Elsevier (66)
- European Journal of Cancer · Elsevier (65)
- Gynecologic Oncology Reports · Elsevier (65)
- Leukemia Research Reports · Elsevier (65)
- Bulletin du Cancer · Elsevier (59)
- Translational Oncology · Elsevier (59)
- Cancer Letters · Elsevier (57)
- Blood Reviews · Elsevier (54)
- Journal of the National Cancer Center · Elsevier (53)
- Leukemia Research · Elsevier (52)
- The Journal of Liquid Biopsy · Elsevier (52)
- Trends in Cancer · Elsevier (49)
- JACC: CardioOncology · Elsevier (46)
- Surgical Oncology Insight · Elsevier (43)
- Clinical Breast Cancer · Elsevier (40)
- ESMO Open · Elsevier (38)
- Cancer Pathogenesis and Therapy · Elsevier (37)
- Clinical Lung Cancer · Elsevier (33)
- Journal of Geriatric Oncology · Elsevier (30)
- Current Problems in Cancer: Case Reports · Elsevier (29)
- Journal of Bone Oncology · Elsevier (27)
- Precision Radiation Oncology · Wiley (25)
- Intelligent Oncology · Elsevier (19)
- Current Problems in Cancer · Elsevier (17)
- Immuno-Oncology and Technology · Elsevier (16)
- npj Precision Oncology · Springer Nature (12)
- Best Practice & Research Clinical Haematology · Elsevier (11)
- MedComm - Oncology · Wiley (10)
- European Journal of Cancer: Supplement · Elsevier (9)
- Nature Reviews Cancer · Springer Nature (9)
- Nature Reviews Clinical Oncology · Springer Nature (8)
- British Journal of Cancer · Springer Nature (7)
- Cancer Cytopathology · Wiley (5)
- BMC Cancer · Springer Nature (0)
- Breast Cancer Research · Springer Nature (0)
- Breast Cancer Research and Treatment · Springer Nature (0)
- Cancer Cell International · Springer Nature (0)
- Cancer Chemotherapy and Pharmacology · Springer Nature (0)
- Cancer and Metastasis Reviews · Springer Nature (0)
- Cardio-Oncology · Springer Nature (0)
- Cellular Oncology · Springer Nature (0)
- Clinical and Translational Oncology · Springer Nature (0)
- Current Breast Cancer Reports · Springer Nature (0)
- Current Hematologic Malignancy Reports · Springer Nature (0)
- Current Oncology Reports · Springer Nature (0)
- Immuno-Oncology · Springer Nature (0)
- Indian Journal of Gynecologic Oncology · Springer Nature (0)
- Indian Journal of Surgical Oncology · Springer Nature (0)
- Journal of Cancer Research and Clinical Oncology · Springer Nature (0)
- Journal of Gastrointestinal Cancer · Springer Nature (0)
- Journal of Mammary Gland Biology and Neoplasia · Springer Nature (0)
- Journal of the Egyptian National Cancer Institute · Springer Nature (0)
- Molecular Cancer · Springer Nature (0)
- Oncology and Therapy · Springer Nature (0)
- Strahlentherapie und Onkologie · Springer Nature (0)
- best practice onkologie · Springer Nature (0)
- A Randomized Phase III Trial of Concurrent Chemoradiotherapy Followed by Durvalumab Consolidation, With or Without Induction Chemo-Immunotherapy, in Patients With Unresectable Locally Advanced Non–Small Cell Lung Cancer: JCOG2510 (PRIME-CRT)
- The Impact of Tumor Immune Microenvironment in EGFR-Mutant Non-Small Cell Lung Cancer on the Efficacy of Osimertinib
- Comparative Effectiveness of First-Line Tyrosine Kinase Inhibitors in ALK-Positive Metastatic Non–Small Cell Lung Cancer by Presence of Brain Metastases
- Low Baseline Absolute Neutrophil Count and Chemotherapy Safety in African American Patients with Advanced Lung Cancer: A Retrospective Cohort Study
- Assessment of Prognostic Value of CEACAM5 Expression Using Archival Tissue and Real-World Evidence of Metastatic Patients with NSCLC in United States
- Racial Disparities in Thymic Epithelial Tumors: Insights From a Multiracial Urban Cohort
- Osimertinib Plus Platinum-based Chemotherapy in Patients With EGFR-Mutated Advanced NSCLC Post-progression on First-Line Osimertinib: ORCHARD
- Durable Response After Pembrolizumab for Recurrent Tracheal Squamous Cell Carcinoma: A Case Report and Focused Literature Review
- Utility of longitudinal serum tumor markers for disease monitoring in advanced NSCLC with actionable genomic alterations
- Safety and Efficacy of Stereotactic body radiotherapy for central and ultracentral Early-Stage Lung Tumors: A Canadian Provincial Cancer Center Experience.
- Transforming the Therapeutic Landscape of HER2-Mutant NSCLC: Emerging First-Line Treatment Strategies
- SAARC Consensus Recommendations for the diagnosis and treatment of non-small-cell lung cancer (NSCLC)
- Beyond Segmentectomy: Stereotactic Body Radiotherapy as a First-Line Option Alongside Surgery for Subsolid Lung Cancer
- Outcomes and Treatment Patterns for Recurrence Following Concurrent Chemoradiation and Consolidation Durvalumab in Locally Advanced, Unresectable NSCLC: A Multi-Center Study
- Local Failure after Consecutive Versus Nonconsecutive Stereotactic Body Radiotherapy for Early-Stage NSCLC: A Systematic Review and Meta-analysis
- Modified CARG Score-Guided First-Line Treatment in Older or Vulnerable Patients With Advanced Non-Small-Cell Lung Cancer: Results of the Randomized, Phase 2 DURATION Trial (AIO-YMO/TRK-0416)
- Pretreatment FDG-PET Biomarkers Predict Regional and Distant Failure but Not Local Recurrence Following Modern Use of Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
- Detection of Actionable Genomic Alterations beyond EGFR, ALK and ROS1 in Non-Small Cell Lung Carcinoma: A Real-World Evaluation of a Pathology-Led Staggered Reflex Predictive Biomarker Testing Strategy in a Resource-Limited Setting
- Real-World Outcomes and Early Progressive Disease Analysis of Nivolumab and Ipilimumab Combination Therapy in Metastatic NSCLC: LIGHT-NING Study 2.5-Year Update
- Clinical And Radiological Predictors of Pathological Response to Chemo-Immunotherapy in Surgically Resected Non-Small Cell Lung Cancer
- De Novo Lung Cancer after Lung Transplantation: Rethinking Surveillance and Early Detection
- Risk of Developing a Subsequent Primary Lung Cancer Among Adult Non-Lung Cancer Survivors: Implications for Lung Cancer Screening and Supportive Care
- Restoration of Lung Cancer Treatment After Successful Management of Aplastic Anemia: A Report of Two Cases Including a Case of Osimertinib Rechallenge
- Stage I Lung Adenocarcinoma in Young Patients (Aged ≤ 50 Years): Beyond Female Nonsmokers
- Isolated Sternal Involvement in Breast Cancer: Is it Truly Stage IV Disease?
- Validity of Post-Neoadjuvancy Sentinel Lymph Node Biopsy in Patients with Clinical Tumor Staging T4 and/or N2 Breast Cancer
- Neoadjuvant Endocrine Therapy for Invasive Lobular Carcinoma: Balancing Positive Margins Against Breast Conservation Outcomes
- Association between preoperative prognostic nutritional index and the risk of recurrence or metastasis after modified radical mastectomy for breast cancer: a single-center retrospective cohort study
- Advances in Breast Cancer Sentinel Lymph Node Localization Modalities: A Systematic Review
- Is it the biology or the nodes? Molecular subtype is not associated with differential outcomes after post-mastectomy radiotherapy in SUPREMO-eligible breast cancer: a retrospective SEER cohort study